Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling

• Glavni autori: Xuemin He (Autor), Siying Wen (Autor), Xixiang Tang (Autor), Zheyao Wen (Autor), Rui Zhang (Autor), Shasha Li (Autor), Rong Gao (Autor), Jin Wang (Autor), Yanhua Zhu (Autor), Dong Fang (Autor), Ting Li (Autor), Ruiping Peng (Autor), Zhaotian Zhang (Autor), Shiyi Wen (Autor), Li Zhou (Autor), Heying Ai (Autor), Yan Lu (Autor), Shaochong Zhang (Autor), Guojun Shi (Autor), Yanming Chen (Autor)
• Format: Knjiga
• Izdano: Elsevier, 2024-06-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) protect against diabetic cardiovascular diseases and nephropathy. However, their activity in diabetic retinopathy (DR) remains unclear. Our retrospective cohort study involving 1626 T2DM patients revealed superior efficacy of GLP-1 RAs in control...